Corrective Action: In January 2024, the internal control structure for grant reimbursement documentation was modified. William Harrison, Controller, will review the cumulative grant reimbursement total for prescription drugs to ensure the total cumulative expenditures do not exceed the $30,000 limit for the grant period. Once reviewed by Mr. Harrison, the grant reimbursement requested will be presented to Judd Nielsen, Grant Evaluator, and Krista Byrd, Program Director, and to Maureen Collins, Executive Director, for their review and approval. In addition, when new grants or continuation funding awards are received, the Controller, William Harrison, Program Director, Krista Byrd, and Grant Evaluator, Judd Nielsen will meet to review all grant documentation to ensure everyone is aware of funding limitations.